Funding news
Thalia Therapeutics Plc logo

Thalia Therapeutics Plc Secures $3.

Recently funded · $3.6M UnknownHospitals and Health CareGBView source

Get the full Thalia Therapeutics Plc company profile

Access contacts, investors, buying signals & more

Open in Dashboard

The complex challenge of delivering RNA-based therapeutics to treat serious diseases just received a financial boost, as Thalia Therapeutics Plc announced it has secured $3.6M in new funding.

The biotechnology company is dedicated to developing innovative RNA-based treatments and advanced delivery technologies, with a specific focus on oncology and cardiovascular disease. Thalia's mission is to overcome the fundamental hurdles of RNA delivery, enabling the creation of targeted, scalable, and clinically meaningful medicines for patients facing significant unmet medical needs.

Other United Kingdom companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Unknown rounds

Companies that recently closed a Unknown round.

#CompanyAmount
1
Wheere logo

Wheere

France

$4.6M
2
Esh-Tech Systems logo

Esh-Tech Systems

Israel

$18.0M
3
Pocket (YC W26) logo

Pocket (YC W26)

United States

$11.0M
4
Unloq logo

Unloq

$1.1M
5
Warwick Acoustics Ltd logo

Warwick Acoustics Ltd

United Kingdom

$8.1M